In addition, in a recent clinical trial, combinatorial therapy using nivolumab and statin improved NSCLC survival rates; however, information regarding the functions of ATO in immune checkpoint regulation in cancer or EV PD-L1-mediated immune regulation is scanty. Here, CD274 is linked to non-small cell lung carcinoma.